Benjamin Graham fit · Defensive deep-value investing
Is Chugai Pharmaceutical Co., Ltd. (4519.T) a Benjamin Graham Stock?
Meets 1/7 Graham criteria - classic deep-value candidate.
79/100
DNot a fit
1/7 criteria passed
+6 sector-quality lift. Top-quintile within its sector on 3 of 5 quality metrics. Raw pillar score 73 → lifted to 79 before grade derivation.
Capped from B to D. Net income negative for most of the last 5 years - Graham required earnings stability What are deal-breaker caps?
Benjamin Graham's Criteria, Applied to 4519.T
P/E ≤ 15
key-
P/B ≤ 1.5
key6.4x
Current ratio ≥ 2
4.2x
Debt / Equity ≤ 1
-
5y profitable
keyNo
Earnings yield ≥ 7%
-
Revenue growing
-0.0%
How 4519.T Scores on Other Strategies
Live Financial Snapshot
Market cap
$12.61T
P/E (TTM)
-
ROIC (TTM)
20.66%
Gross margin
71.09%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is 4519.T's Benjamin Graham fit score?
4519.T scores 79/100 on our Benjamin Graham fit engine - grade D. Meets 1/7 Graham criteria - classic deep-value candidate.
Does Benjamin Graham actually own 4519.T?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends 4519.T.
How often is this score updated?
4519.T's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends 4519.T.